BE506950A - - Google Patents
Info
- Publication number
- BE506950A BE506950A BE506950DA BE506950A BE 506950 A BE506950 A BE 506950A BE 506950D A BE506950D A BE 506950DA BE 506950 A BE506950 A BE 506950A
- Authority
- BE
- Belgium
- Prior art keywords
- terramycin
- salt
- solution
- sep
- process according
- Prior art date
Links
- IWVCMVBTMGNXQD-PXOLEDIWSA-N Oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 claims description 70
- 229960000625 Oxytetracycline Drugs 0.000 claims description 66
- 229940063650 Terramycin Drugs 0.000 claims description 66
- 239000000243 solution Substances 0.000 claims description 42
- 150000003839 salts Chemical class 0.000 claims description 37
- 239000011780 sodium chloride Substances 0.000 claims description 37
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 22
- 239000002244 precipitate Substances 0.000 claims description 22
- 238000000855 fermentation Methods 0.000 claims description 18
- 230000004151 fermentation Effects 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 17
- 239000002184 metal Substances 0.000 claims description 17
- 239000002253 acid Substances 0.000 claims description 16
- 150000007530 organic bases Chemical class 0.000 claims description 16
- 239000007864 aqueous solution Substances 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- -1 alkyltrimethylammonium halide Chemical class 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 4
- 150000002739 metals Chemical class 0.000 claims description 3
- 150000002576 ketones Chemical class 0.000 claims description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N Diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims 1
- 150000003863 ammonium salts Chemical class 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 46
- 235000010633 broth Nutrition 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
- 230000003115 biocidal Effects 0.000 description 22
- 239000000047 product Substances 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 150000002500 ions Chemical class 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000007792 addition Methods 0.000 description 8
- 230000002829 reduced Effects 0.000 description 8
- SVDOODSCHVSYEK-IFLJXUKPSA-N (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydron;chloride Chemical compound Cl.C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O SVDOODSCHVSYEK-IFLJXUKPSA-N 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000005712 crystallization Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000012452 mother liquor Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L cacl2 Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 media Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- MTNDZQHUAFNZQY-UHFFFAOYSA-N 2-Imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 2
- LRJAGMBMPSXEFP-UDPUMDPQSA-N 2-[[[(1R)-1-[[(2R)-2-[3-acetamido-2-[[[(2R,3S,4R)-3,4-dihydroxy-5-(5-iodo-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]ethyl]-hydroxyphosphoryl]methyl]penta Chemical compound CC(=O)NC1C(O[C@H](C)C(=O)N[C@@H](C)P(O)(=O)CC(CCC(O)=O)C(O)=O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)C(N2C(NC(=O)C(I)=C2)=O)O1 LRJAGMBMPSXEFP-UDPUMDPQSA-N 0.000 description 2
- 229940088710 Antibiotic Drugs 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L Calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000008043 acidic salts Chemical class 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 150000001348 alkyl chlorides Chemical class 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- FJDUDHYHRVPMJZ-UHFFFAOYSA-N nonan-1-amine Chemical compound CCCCCCCCCN FJDUDHYHRVPMJZ-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229940064005 Antibiotic throat preparations Drugs 0.000 description 1
- 229940083879 Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE Drugs 0.000 description 1
- 229940042052 Antibiotics for systemic use Drugs 0.000 description 1
- 229940042786 Antitubercular Antibiotics Drugs 0.000 description 1
- 229940093922 Gynecological Antibiotics Drugs 0.000 description 1
- 229940024982 Topical Antifungal Antibiotics Drugs 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 150000003868 ammonium compounds Chemical group 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- MHZGKXUYDGKKIU-UHFFFAOYSA-N decan-1-amine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002070 germicidal Effects 0.000 description 1
- 239000001963 growth media Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 229940079866 intestinal antibiotics Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940005935 ophthalmologic Antibiotics Drugs 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000036961 partial Effects 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 230000001376 precipitating Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE506950A true BE506950A (fi) |
Family
ID=147058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE506950D BE506950A (fi) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE506950A (fi) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2871264A (en) * | 1955-03-28 | 1959-01-27 | American Cyanamid Co | Tetracycline extractions |
| US2873276A (en) * | 1956-05-18 | 1959-02-10 | Pfizer & Co C | Antibiotic purification and complex compounds |
| US2875247A (en) * | 1956-12-21 | 1959-02-24 | American Cyanamid Co | Refining of tetracycline antibiotics by direct mash extraction |
| US2886595A (en) * | 1958-09-30 | 1959-05-12 | Bristol Lab Inc | Tetracycline recovery |
| US2907693A (en) * | 1956-04-30 | 1959-10-06 | Pfizer & Co C | Antibacterial compositions comprising a tetracycline-type antibiotic and an alkyl phenoxyethoxyethyl dialkylbenzyl ammonium salt |
| US3005754A (en) * | 1957-08-16 | 1961-10-24 | Bristol Myers Co | Tetracycline formulations |
| US3335055A (en) * | 1961-08-30 | 1967-08-08 | American Cyanamid Co | More stable and more soluble tetracycline compositions suitable for parenteral use and method of preparing same |
-
0
- BE BE506950D patent/BE506950A/fr unknown
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2871264A (en) * | 1955-03-28 | 1959-01-27 | American Cyanamid Co | Tetracycline extractions |
| US2907693A (en) * | 1956-04-30 | 1959-10-06 | Pfizer & Co C | Antibacterial compositions comprising a tetracycline-type antibiotic and an alkyl phenoxyethoxyethyl dialkylbenzyl ammonium salt |
| US2873276A (en) * | 1956-05-18 | 1959-02-10 | Pfizer & Co C | Antibiotic purification and complex compounds |
| US2875247A (en) * | 1956-12-21 | 1959-02-24 | American Cyanamid Co | Refining of tetracycline antibiotics by direct mash extraction |
| US3005754A (en) * | 1957-08-16 | 1961-10-24 | Bristol Myers Co | Tetracycline formulations |
| US2886595A (en) * | 1958-09-30 | 1959-05-12 | Bristol Lab Inc | Tetracycline recovery |
| US3335055A (en) * | 1961-08-30 | 1967-08-08 | American Cyanamid Co | More stable and more soluble tetracycline compositions suitable for parenteral use and method of preparing same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2658078A (en) | Solvent extraction of oxytetracycline | |
| BE506950A (fi) | ||
| FR2688506A1 (fr) | Procede de preparation de sels de l'acide clavulanique. | |
| FR2543554A1 (fr) | Procede ameliore pour la purification de la tylosine | |
| JPS60217897A (ja) | 乳酸の分離精製方法 | |
| FR2574790A1 (fr) | Procede de preparation d'acide glutamique a l'etat cristallise de preference sous forme de son sel sodique ou msg; acide glutamique, msg, sels et concentrat organique obtenus par ce procede | |
| BE535983A (fi) | ||
| CA1213884A (fr) | Procede pour la separation et l'isolement du nosiheptide | |
| BE505856A (fi) | ||
| FR2691716A1 (fr) | Procédé de préparation de sels de déféroxamine de grande pureté. | |
| BE557360A (fi) | ||
| BE536231A (fi) | ||
| FR2479260A1 (fr) | Procede de separation et de recuperation de la coproporphyrine et de l'uroporphyrine d'un bouillon de culture | |
| BE536274A (fi) | ||
| FR2552765A1 (fr) | Procede de conversion de corrinoides produits par des microorganismes en cyanocorrinoides | |
| BE512762A (fi) | ||
| BE572382A (fi) | ||
| BE511139A (fi) | ||
| BE544260A (fi) | ||
| BE550641A (fi) | ||
| BE563386A (fi) | ||
| BE514283A (fi) | ||
| BE449317A (fi) | ||
| FR2471384A1 (fr) | Procede de preparation de tartrate d'ergotamine | |
| FR2587362A1 (fr) | Procede pour la separation des corrinoides |